<DOC>
	<DOCNO>NCT01898325</DOCNO>
	<brief_summary>The investigated cohort examine liver spleen fibrosis patient Gaucher disease divide two group , naive GD patient GD patient treat ERT . As liver biopsy patient recommend risk bleed use Fibroscan safe diagnostic accuracy regard liver ( &amp; Spleen ) fibrosis . Estimating spleen fibrosis innovative approach liver disease Gaucher . The evaluation fibrosis new safe method could avoid complication antiinvasive procedure GD patient . The addition fibrosis biomarkers help patient score evaluation . The finding liver spleen stiffness evaluate native ERT treat Gaucher patient order ass ERT effect fibrosis . The Aims : 1 ) To assess liver spleen stiffness measurement use fibroscan evaluate liver spleen fibrosis patient GD . 2 ) To compare elastography two cohort GD patient : ERT treat naïve GD patient two control group patient : healthy Non Alcoholic Steatohepatitis ( NASH ) patient . 3 ) To correlate elastography finding clinical laboratory data four patient group focus Gaucher disease manifestation GD severity . To compare elastography GD naïve ERT treat patient .</brief_summary>
	<brief_title>Assessment Of Liver Spleen Fibrosis Patients With Gaucher Disease Using Fibroscan</brief_title>
	<detailed_description>The investigated cohort include 4 group patient 20 probands group include : 1 ) Naïve GD patient 2 ) GD treat ERT 3 ) Healthy control 4 ) Patients NonAlcoholic Steatohepatitis ( NASH ) follow hepatology unit Ziv Hospital healthy control . Serum fibrosis marker test include : Bilirubin , GGT , Haptoglobin , AST , ALT .The finding spleen liver fibrosis correlate disease severity usingZimran 's Severity Score Index ( SSI ) liver function test , serology viral hepatitis , GDbiomarkers , hemoglobin , platelet level , GD severity score . Protein C measure group patient Protein C activity may use sensitive marker hepatocellular damage even patient mild liver affection .Also Patients cirrhosis possess imbalance pro-coagulant versus anticoagulantactivity due increase factor VIII decrease protein C .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Gaucher Disease</mesh_term>
	<criteria>Diagnosis Gaucher treatment without treatment . Healthy control . Patients Non Alcoholic Steatohepatitis ( NASH ) follow hepatology unit . • Active liver disease , cirrhosis patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Fibrosis</keyword>
	<keyword>Gaucher disease</keyword>
</DOC>